Search

Filters
Clear All
  • 23

Phase

  • 2
  • 3
  • 1
  • 6
  • 10
  • 22
  • 4

Found 23 Lung Disease trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

N
Naoyuki Saito, MD
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of …
M
Mrunal Patel
100 years or below
All genders
Define long-term CLAD phenotype of lung transplant recipients whoparticipated in LTOG cohort studies Determine the long-term functional status and well-being of lungtransplant recipients who participated in LTOG cohort studies
R
Rohan Maniar
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-SC …
V
Vijay Khatri
100 years or below
All genders
This study investigates the collection of fresh blood from patients with Stage IV Non-Small Cell Lung Cancer (NSCLC). NSCLC is a type of lung cancer that is characterized by the uncontrolled growth of cells in the lung tissue. Stage IV indicates that the cancer has spread beyond the lungs to …
V
Vijaya L. Kakani, MD
18 years - 100 years
All genders
Phase 3
Interventional
This study investigates the effectiveness of adding an investigational medication with pembrolizumab after surgery in treating non-small cell lung cancer (NSCLC) for participants who did not achieve a complete response after initial treatment. NSCLC is a type of lung cancer that can affect different parts of the lung, and this …
J
Jonathan L. Berkowitz, MD, PhD
18 years - 100 years
All genders
Phase 3
Interventional
This study investigates an investigational medication for people with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called KRAS G12C. The purpose is to compare the investigational medication with other treatments that target the same genetic change, to see which works better and how it affects …
K
Kevin Shiue
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. …
R
Rohan Maniar
18 years - 100 years
All genders
Phase 2/3
This study investigates the effects of adding an investigational medication, cemiplimab, to the usual treatment of docetaxel and ramucirumab for patients with stage IV or recurrent non-small cell lung cancer. This type of lung cancer is advanced and may have returned after previous treatment. Cemiplimab is a monoclonal antibody that …
B
Bharathi Muthusamy
18 years - 100 years
All genders
What is the purpose of this study?This is a descriptive, cross-sectional study, which will involve a one-time survey for patients with lung cancer (any histology), pancreatic adenocarcinoma, renal cell carcinoma, and urothelial carcinoma.  Patients in this study will be recruited in a prospective basis during their in-person visit to the outpatient …
A
Alexia Torke
18 years - 100 years
All genders
This study investigates the impact of informational support versus spiritual care on patients with cancer. Cancer patients often face challenges in coping with their condition and making treatment decisions. Religion and spirituality can play significant roles in their experience. Therefore, this study will evaluate a spiritual care intervention delivered by …
11 - 20 of 23